ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0815

Neuropathic-like Pain Characteristics Predict Worse Pain Outcomes in Early Rheumatoid Arthritis: a Prospective Cohort Study with Embedded Neuroimaging Evaluation

Eoin Kelleher1, Amanda Wall1, Isabelle Brennan2, Robert Murphy1, Antonella Delmis1, John Davis3, Vishvarani Wanigasekera4, Irene Tracey1 and Anushka Irani5, 1University of Oxford, Oxford, United Kingdom, 2University of Cambridge, Cambridge, United Kingdom, 3Mayo Clinic, Rochester, MN, 4University of Oxford, Oxford, 5Mayo Clinic, Jacksonville, FL

Meeting: ACR Convergence 2025

Keywords: Neuroimaging, pain, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: Abstracts: Pain in Rheumatic Disease Including Fibromyalgia (0813–0818)

Session Type: Abstract Session

Session Time: 3:30PM-3:45PM

Background/Purpose: Despite effective control of inflammation in rheumatoid arthritis (RA), persistent and severe pain remains a clinical challenge. Dysregulated pain processing in the central nervous system (“central sensitization”) may underlie this disconnect. The PainDETECT questionnaire, originally developed to identify neuropathic pain, may capture features of central sensitization. We hypothesised that neuropathic-like pain at diagnosis predicts worse pain prognosis in early RA, independent of inflammation. We also explored associated brain activation patterns using functional neuroimaging.

Methods: In this prospective cohort study, adults with newly diagnosed RA in Oxfordshire completed the PainDETECT questionnaire at baseline. The primary outcome, bodily pain, was measured using the SF-36 Bodily Pain Subscale (BPS) at baseline, 3, 6, and 12 months. Inflammatory markers (CRP) were monitored longitudinally. Linear mixed-effects models examined associations between PainDETECT and BPS and CRP over time. A subset of 27 participants underwent task-based fMRI, assessing brain responses to evoked pressure pain.

Results: Among 158 participants (mean age 58.4 years; 35% male), higher baseline PainDETECT scores were associated with significantly worse bodily pain throughout follow-up (adjusted β= -0.43; 95%CI: -0.84 to -0.02; P=0.043), independent of socio-demographics, lifestyle, comorbidities, depression, and anxiety. No association was found between PainDETECT and CRP. On neuroimaging,higher PainDETECT scores correlated with increased activation in the left insula, dorsal anterior cingulate cortex (dACC), and left amygdala during evoked wrist pain.

Conclusion: Neuropathic-like pain at diagnosis predicts a worse pain prognosis in early RA, independently of inflammation. Early identification may support more targeted and effective pain management.

Supporting image 1Schematic of the task-based functional MRI (tfMRI) protocol. Participants received alternating blocks of pressure pain (50 N) and light touch stimuli to the left wrist (typically affected in RA) and the left index finger nailbed (control site), during two 10-minute scan sessions on a 3T MRI scanner. Stimuli were applied manually using an MR-compatible algometer in a pseudorandomised order, guided by auditory cues. First-level contrasts modelled pain > touch at each site. Second-level contrasts compared wrist > nailbed activation, and group-level analyses examined associations with PainDETECT across the whole brain.

Supporting image 2Lines represent individual raw patient trajectories of bodily pain (A) and C-reactive protein (CRP, B) over time, with mean values in bold. Shaded areas indicate 95% confidence intervals. Participants (N = 158, 91 scoring ≥13) were followed for one year. Neuropathic-like pain measured using the PainDETECT questionnaire (cutoff: ≥13 indicates probable neuropathic pain). Note higher values of SF36-BPS indicate more severe bodily pain. CRP values were taken from linked healthcare records during follow-up, and were grouped into average CRP in each time period.

Supporting image 3Higher PainDETECT (PDQ) scores are associated with greater activity in the left Insula, dorsal anterior cingulate cortex (dACC), and left amygdala after whole brain correction. Whole brain group-level activation maps for painful vs. non-painful stimulation of the left wrist vs. left nailbed contrast with PainDETECT scores. Maps are overlaid on a standard MNI152 T1-weighted brain template and thresholded at Z > 3.1.

Higher PainDETECT scores at baseline are associated with significantly greater neuronal response in the left insula, dACC, and left amygdala. The y-axes show the induced effects of painful stimulation to the left wrist as a percentage BOLD signal change, defined as X = (Xpain (wrist) – Xno pain (wrist)) – (Xpain (nailbed) – Xno pain (nailbed)). Shaded areas represent the 95% confidence interval. Pearson correlation coefficients (r) are reported.

N&#3f27 participants who underwent neuroimaging.


Disclosures: E. Kelleher: None; A. Wall: None; I. Brennan: None; R. Murphy: None; A. Delmis: None; J. Davis: Pfizer, 5, Remission Medical, 1, 9, 10, Rheumasense, 1, 9, 10; V. Wanigasekera: None; I. Tracey: None; A. Irani: None.

To cite this abstract in AMA style:

Kelleher E, Wall A, Brennan I, Murphy R, Delmis A, Davis J, Wanigasekera V, Tracey I, Irani A. Neuropathic-like Pain Characteristics Predict Worse Pain Outcomes in Early Rheumatoid Arthritis: a Prospective Cohort Study with Embedded Neuroimaging Evaluation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/neuropathic-like-pain-characteristics-predict-worse-pain-outcomes-in-early-rheumatoid-arthritis-a-prospective-cohort-study-with-embedded-neuroimaging-evaluation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neuropathic-like-pain-characteristics-predict-worse-pain-outcomes-in-early-rheumatoid-arthritis-a-prospective-cohort-study-with-embedded-neuroimaging-evaluation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology